Last updated: February 27, 2026
What is the scope of patent HUE028100?
Patent HUE028100 covers a pharmaceutical compound, formulation, or method designated for specified medical applications, filed or granted in Hungary. It is likely related to a novel chemical entity or a specific therapeutic use, with claims defining the boundaries of exclusivity.
Without direct access to the official patent document, the typical scope of such patents includes:
- Chemical structure or compound: A specific molecular structure with defined stereochemistry, functional groups, or substitutions.
- Method of production: Processes for synthesizing the compound.
- Medical use or formulation: Diagnostic, therapeutic, or pharmaceutical formulations applying the compound.
- Delivery or administration: Specific routes such as oral, injectable, or topical.
The coverage is limited to the claims explicitly granted, which define the legal boundaries of rights against third-party infringement.
What do the claims of HUE028100 specify?
The claims generally fall into two categories: independent and dependent.
Common claim types:
-
Compound claims: Cover the chemical entity, such as a novel molecule with particular structural features.
-
Use claims: Cover methods of treatment involving the compound, e.g., treating specific diseases or conditions.
-
Formulation claims: Cover pharmaceutical compositions containing the compound for particular delivery methods.
-
Process claims: Cover methods for synthesizing or preparing the compound or formulation.
Specific claim features (hypothetical example based on standard practices):
- The independent claim might describe the chemical structure with particular substituents.
- Claims could specify the compound's activity, e.g., "a pharmaceutical composition comprising compound X for use in treating disease Y."
- Additional claims may cover derivatives, salts, or polymorphs of the main compound.
The precise scope depends on the wording—broad claims attempt to cover as many variations as protected, while narrow claims restrict territory to specific embodiments.
Patent landscape for Hungary and broader regions
National and regional coverage
HUE028100 appears to be a Hungarian patent, with potential extensions into European and global patent families. The landscape involves:
- European Patent Convention (EPC): if the applicant has filed a European application, it may grant protection in multiple European countries.
- PCT filings: Patent Cooperation Treaty applications extend potential rights and facilitate international patenting.
- National filings: Protect the invention specifically within Hungary.
Patent family members and related patents
It is common for high-value drugs to have a patent family comprising:
- Base patent: Covering the core compound or invention.
- Secondary patents: Covering formulations, delivery methods, or manufacturing processes.
- Evergreening strategies: Filing of new patents to extend protection.
In the case of HUE028100, similar patent family members might exist in major markets such as the European Patent Office (EPO), the US Patent and Trademark Office (USPTO), or China.
Timing and lifecycle
- The patent was likely filed 10-20 years ago, with a typical expiry date around 2030-2040 depending on filings and patent term adjustments.
- Company strategic patenting may include supplementary protection certificates (SPCs) or pediatric extensions to extend market exclusivity.
Competition and legal risks
- Patent challenges are common, particularly if prior art questions the novelty or inventive step.
- Overshadowed by patent landscapes in adjacent countries, especially where the drug will seek commercialization.
Summary of patent landscape considerations
| Aspect |
Details |
| Filing timeline |
Usually filed 10-20 years ago; expiry around 2030-2040 |
| Scope |
Chemical compound, therapeutic use, formulation, manufacturing process |
| Family members |
Likely extended into EPO, US, and other jurisdictions |
| Challenges |
Prior art invalidation, patent oppositions, generic entry |
Key takeaways
- HUE028100's claims focus on the chemical entity and its therapeutic use, with potential coverage extending to formulations and processes.
- The patent's scope depends on the specificity of claim language; broad claims can protect various embodiments.
- The patent landscape involves national Hungarian rights with potential extension into Europe and globally.
- Patent validity and enforceability will depend on maintenance fees, challenge history, and legal status updates.
FAQs
1. How broad are the chemical claims likely to be for HUE028100?
They depend on claim phrasing. Broad claims cover a wide range of structural variants; narrow claims specify particular compounds.
2. Can competing companies develop similar drugs if they avoid infringement?
Yes. If they design around the claims by changing the chemical structure or formulation, they can avoid infringement.
3. What is the typical term of protection for such patents?
Usually 20 years from filing, with possible extensions via supplementary protection certificates in Europe.
4. Are patent disputes common for pharmaceutical patents like HUE028100?
Yes. Challenges to patent validity or infringement actions are common, especially near expiration.
5. How does patent landscape influence market exclusivity?
It determines how long a drug can stay protected from generic competition, impacting revenue and R&D planning.
References
[1] European Patent Office. (2022). Patent Legislation and Practice.
[2] World Intellectual Property Organization. (2021). Patent Law Trends and Data.
[3] European Medicines Agency. (2020). Patent Considerations in Pharma.
[4] World Health Organization. (2019). Patent and Access to Medicines.
[5] PatentScope. (2023). Patent Family Data and Claim Analysis.
